ADVANCED POLICY CONSULTING, LLC for AMGEN USA INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Opposition to the Center for Medicare and Medicaid Innovation's (CMMI) new Part B Drug model, which would put patient access and quality of care at risk.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW MCGINLEY | — |
Taxation/Internal Revenue Code TAX
Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. The international tax code as it relates to the treatment of U.S. companies doing business in Puerto Rico. H.R. 4900, the Puerto Rico Oversight, Management, and Economic Stability Act (PROMESA), as it relates to the tax treatment of U.S. companies doing business in Puerto Rico.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW MCGINLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.